X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Groupe Rocher Enters Into A Definitive Agreement To Acquire Arbonne International

Content Team by Content Team
2nd February 2018
in Health & Nutrition

In order to complement and expand its portfolio of strong brands and fulfill its growth objectives, particularly outside the euro area, Groupe Rocher is pleased to announce it has entered into a definitive agreement to acquire Arbonne International, a leader in direct selling of botanically based beauty, personal care and nutrition products. Arbonne offers a wide range of vegan skincare, bath and body, and nutrition and makeup products.

Arbonne International, whose holding company is Natural Products Group (NPG), is headquartered in Irvine, California. NPG also owns Nature’s Gate, a personal care brand, which is also part of this acquisition. With a production site and four integrated distribution sites, Arbonne is a global business with sales revenue in excess of 550 million dollars (450 million euros).

Founded in Switzerland in 1975, and brought to the U.S. in 1980, Arbonne was created to fulfill the vision of founder Petter Mørck to develop botanically based skincare, cosmetics and nutrition products that are better for both consumers and the planet, while also providing an opportunity for people to become financially independent by joining a direct selling network.

Today, approximately 800 employees and over 250,000 active independent consultants contribute to the success of the Arbonne brand whose botanically based, vegan, gluten- and GMO-free products are sold in the United States, Canada, United Kingdom, Australia, New Zealand, Taiwan and Poland.

WHY IS GROUPE ROCHER ENTERING INTO THIS AGREEMENT TO ACQUIRE ARBONNE INTERNATIONAL?

Groupe Rocher and Arbonne have many things in common: The concept of robust brands that share real values, high quality and innovation standards, a wide range of natural products and a strong commitment to sustainability. Arbonne expects to be able to benefit from the resources and expertise offered by Groupe Rocher, thanks to the strength of its network (consumers, suppliers, partners).

Bris Rocher, CEO of Groupe Rocher, stated: “This acquisition will be a real asset that will enable us to strengthen our positioning in the direct selling channel, which has seen an upturn over the past few years. We also have a heritage of providing employment opportunities —dating back to my grandfather, our founder, Yves Rocher, who cared deeply about providing employment since he started his business. This, combined with our direct selling know-how, should foster company growth and longevity.”

Said, Kay Zanotti, CEO of Arbonne: “We share with Groupe Rocher commitments to pure, botanically based products and sustainability, as well as a long-term business vision that is grounded in family values. We are particularly pleased with Groupe Rocher’s keen appreciation of the many benefits of the direct selling model in providing flexible income opportunities, and a positive community of professional growth for individuals.”

Thanks to recent investment in the digitization of the direct selling network, Arbonne can help Groupe Rocher enhance the direct selling model. Arbonne has implemented a state-of-the-art IT platform that will facilitate the move from traditional direct selling to “social selling.”

This pending acquisition (the value of which has not been released) will round off the portfolio of Groupe Rocher brands and positions the family-owned, Breton company as an operator that is growing more than ever before. Groupe Rocher has been able to reposition its business over time, thanks to its decisions regarding distribution channels and its commitments as an integrated company.

ABOUT GROUPE ROCHER

The Groupe Rocher is a profitable and independent family-run group (over 99% owned by the founder’s family and with a philosophy of “creative entrepreneurship”) with an original positioning (producer, harvester, manufacturer and distributor). Groupe Rocher sales (from nine brands dedicated to women’s beauty and well-being: Yves Rocher, Petit Bateau, Stanhome, Dr. Pierre Ricaud, Daniel Jouvance, Kiotis, ID Parfums, Flormar and Sabon) amounted to more than €2 billion in 2017.

More than 17,000 employees work together to ensure the destiny of the group’s brands, and the group has also created over 350,000 indirect jobs. The business is an integrated group, characterized by the diversity and synergies of its distribution methods: Remote sales (by correspondence, telephone, Internet), in-store sales (over 6,000 points of sale across the world — brands combined) and direct sales.

http://www.arbonne.com

Previous Post

Functional Formularies® Announces Groundbreaking Clinical Trial With Organic Whole Foods Nutrition

Next Post

Diet may influence the spread of a deadly type of breast cancer, study finds

Related Posts

Health & Nutrition

Vitafoods India 2025 Ignites Powerful Knowledge Exchange, Elevating the Future of Nutraceuticals

7th February 2025
Danone Ltd invests €100m in specialized nutrition in China
Health & Nutrition

Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform

13th February 2024
Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer
Health & Nutrition

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

13th January 2024
Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health
Health & Nutrition

Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

13th January 2024
Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition
Health & Nutrition

Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

13th January 2024
Nestle unveils science-backed innovation for early-life nutrition
Health & Nutrition

Nestle unveils science-backed innovation for early-life nutrition

13th January 2024
Next Post

Diet may influence the spread of a deadly type of breast cancer, study finds

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In